StreetAlpha.app
Home › Stocks › TLSI

TriSalus Life Sciences, Inc. (TLSI)

$2.32
▲ +6.67%
LAST CLOSE · NOV 20

TriSalus Life Sciences makes the TriNav medical device and sells it mainly to hospitals and physicians. It last closed at $2.32 on Nov 20, up 6.67% on the day. The next earnings report for TLSI is expected around Mon, Jan 11, 2027. For the quarter ended Sep 2026, TLSI reported EPS of -$0.15 on revenue of $12.9M, with revenue up 11.3% from a year ago. Over its last 8 reports the stock moved an average of 12.3% the session after earnings. Over the last 12 months TLSI insiders bought $3.9M of stock on the open market and sold $141K, according to SEC Form 4 filings.

AI Auto Pilots
Is TLSI in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold TLSI.

Key Stats

Last 12 months
Results
Revenue
$46.4M
+15.4% vs a year ago
Net income
−$26.3M
−56.6% margin
EPS (diluted)
−$0.41
Free cash flow
−$24.7M
−53.3% margin
Valuation
Market cap
$143.1M
61.7M shares
P/E
–
No P/E while losing money
Price to sales
3.1
Market cap over revenue
Dividend yield
None
No dividend in 12 months
Balance sheet
Cash & equivalents
$41.1M
At Sep 30
Debt
$32.4M
At Sep 30
Shareholder equity
$680K
Shares outstanding
61.7M
At Nov 6
Fiscal year endsDecember
ExchangeNasdaq
Financials history
FY2022: $12.4M$12.4MFY2022FY2023: $18.5M$18.5MFY2023FY2024: $29.4M$29.4MFY2024FY2025: $45.2M$45.2MFY2025

From TLSI's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Nov 10). Last 12 months adds up the four latest quarters.

Next report
Jan 11
Estimated date · Time not announced
Reported EPS
-$0.15
Quarter ended Sep 2026
Year ago EPS
-$0.96
Same quarter last year
Revenue
$12.9M
+11.3% vs a year ago
Estimates and implied move
Consensus forecasts and the move options price in
EPS by quarter (GAAP)
Dec 2024: -$0.40Dec '24Mar 2025: -$0.39Mar '25Jun 2025: -$0.27Jun '25Sep 2025: -$0.96Sep '25Dec 2025: -$0.12Dec '25Mar 2026: $0.03Mar '26Jun 2026: -$0.16Jun '26Sep 2026: -$0.15Sep '26Latest -$0.15
Revenue by quarter
Dec 2024: $8.3MDec '24Mar 2025: $9.2MMar '25Jun 2025: $11.2MJun '25Sep 2025: $11.6MSep '25Dec 2025: $13.2MDec '25Mar 2026: $8.9MMar '26Jun 2026: $11.4MJun '26Sep 2026: $12.9MSep '26Latest $12.9M
How TLSI moved after its last 8 reports
Average move the session after a report ±12.3%
Nov 10, 2026Time not announced−11.5%
Aug 6, 2026After the close+15.2%
May 12, 2026After the close−41.5%
Mar 5, 2026After the close−6.4%
Jan 12, 2026Time not announced+1.2%
Nov 13, 2025After the close+3.9%
Aug 12, 2025After the close+8.2%
Apr 30, 2025Time not announced−10.3%
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha's call on TLSIStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in

Analyst Ratings & Price Targets

Analyst Ratings →
AI Starter and AI Pro
Full analyst coverage on TLSI
  • Every upgrade, downgrade and initiation as it happens
  • Every price target change, raised or cut
  • Consensus rating with the average, high and low targets
  • Each firm's full rating history on TLSI

Technical Analysis

TLSI · as of the Nov 20 close · updated each morning
Downtrend, nearing oversold

The stock is 33% below its 20 day and 64% below its 50 day average. It is 82% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 32), near oversold. The nearest support is the Pivot at $2.29, and the nearest resistance the Pivot R1 at $2.40.

Short trendBearish
Long trendBearish
MomentumWeak
StretchNear oversold
VolatilityHigh, 14.4%/day
Key levels
$7.9552 week high+242.7%
$4.27100 day average+84.1%
$4.22200 day average+81.9%
$3.8050 day average+63.8%
$3.68Swing high (Jun 1)+58.6%
$3.0820 day average+32.8%
$2.40Pivot R1+3.4%
$2.32Last close
$2.29Pivot−1.3%
$2.22Pivot S1−4.3%
$2.1752 week low−6.5%
$2.17Swing low (Nov 16)−6.5%
Indicators
RSI (14)32.40Weak, oversold below 30Neutral
MACD-0.46Below its signal lineBearish
Stochastic8.2Near the bottom of its rangeOversold
ADX (14)27.4Trending down
Williams %R-91.5Oversold below −80, overbought above −20Oversold
CCI (20)-86.0Oversold below −100, overbought above 100Neutral
Rate of change−28.6%Change over 10 sessionsBearish
ATR (14)$0.33Typical daily range, 14.4% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for TLSI

What happened before

See how TLSI did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.

November seasonalityHow TLSI usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.

Seasonality

How TLSI has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2021.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D
Whale options flow for TLSIHow many large options trades hit TLSI, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in

See today’s whale options flow across the market →

TLSI Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Neutral
Strongly bearishNeutralStrongly bullish
  • ●36 buying vs 35 selling
  • ▼Held by funds -0.9 pts
  • ▲Funds holding +3
  • ▲Superinvestors: 1 added, 0 cut
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding8279+3.8%
In funds' top 10110.0%
Held by funds36.0%36.9%−0.9 pts
New / increased11 / 2511 / 45−35.7%
Reduced / sold out29 / 610 / 15+40.0%
Put/call ratio–––
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See TLSI institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

TLSI Insider Trading

All filings →
Insider trading · 12 months
Insiders are net buyers
Bought$3.9M13 buys · 6 insiders
Sold$141K10 sales · 5 insiders
Cluster buy: 3 insiders bought $294K between Nov 12 and Nov 18.
2026-02 bought $1.8M2026-03 sold $134K2026-05 bought $1.8M2026-05 sold $1K2026-10 sold $4K2026-11 bought $294K2026-11 sold $1KDecMarJunSep
BoughtSoldlast 12 months
Trade dateInsiderTypeSharesPriceValue
Nov 18Mary T SzelaCEO and PresidentBuy65,192$2.46$160K
Nov 17Gary B. GordonDirectorBuy10,000$2.20$22K
Nov 16Richard MarshakChief Commercial OfficerSale544$2.43$1K
Nov 12Mats WahlstromDirectorBuy50,000$2.24$112K
Oct 5Jennifer StevensChief Regulatory OfficerSale316$4.39$1K
Oct 5Richard MarshakChief Commercial OfficerSale325$4.39$1K
Every insider buy and sale for TLSI over 2 years, with a link to each SEC filing. AI Pro members can get an alert the moment an insider trades.See TLSI insider trades →

From SEC Form 4 filings by TLSI's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.

AI Auto Pilots

Paper trading

StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether TLSI is in one of them and how their past TLSI trades turned out.

TLSI in the AI portfolios
Loading…

TLSI News Tone and Price

Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered TLSI in an article yet. Here's the latest on the wider market.

TLSI in the news

About TriSalus Life Sciences

TriSalus Life Sciences is a medical device company based in Westminster, Colorado. It sells its TriNav device to hospitals and physicians, often through consignment agreements. The company is also developing other products that are still in preclinical studies and clinical trials. Its customers are mainly hospitals and the physicians who use its products to treat patients.

Headquarters
Westminster, CO